DRUG

Trailing Twelve Months (TTM) Metrics

Refreshed dailyAbout this data

Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-2.51
Operating CF/Share$-2.54
Free CF/Share$-2.54
Cash/Share$31.35
Book Value/Share$31.35
Tangible Book/Share$31.35
Equity/Share$31.35
Interest Debt/Share$0.01
CapEx/Share$0.00
Dividend/Share$0.00
Valuation (TTM)
Market Cap$690.88M
Enterprise Value$382.92M
P/E Ratio-24.34P/S Ratio0.00
P/OCF Ratio-27.79
P/FCF Ratio-27.67
P/B Ratio2.25
P/TB Ratio2.25
EV/Sales0.00
EV/EBITDA-9.63
Graham Valuation
Graham Number--
Graham Net-Net$31.18
Profitability (TTM)
Earnings Yield-3.56%FCF Yield-3.61%ROE-12.56%ROIC-12.92%Return on Tangible Assets-7.96%
Dividend (TTM)
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF-0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00
Debt/Market Cap0.00
Net Debt/EBITDA7.75
Current Ratio121.97Interest Coverage-2336.36xIncome Quality1.01
Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding15127 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.02x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$308.16M
Working Capital$308.11M
Invested Capital$308.16M
Intangibles/Assets0.00%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.